HSP40/DNAJB1 Antibody (k1C7) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-04302B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Western Blot
Label
Biotin
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # k1C7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for HSP40/DNAJB1 Antibody (k1C7) [Biotin]
Immunogen
Recombinant human Hsp40/DNAJB1 (1-340aa) purified from E. coli
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Applications for HSP40/DNAJB1 Antibody (k1C7) [Biotin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: HSP40/DNAJB1
Long Name
Heat Shock 40 kDa Protein
Alternate Names
DNAJB1, Hdj1, HSPF1
Gene Symbol
DNAJB1
Additional HSP40/DNAJB1 Products
Product Documents for HSP40/DNAJB1 Antibody (k1C7) [Biotin]
Product Specific Notices for HSP40/DNAJB1 Antibody (k1C7) [Biotin]
This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...